|
|
Article: Bivalirudin surpasses heparin on post-PCI transfusion rate.(Cardiovascular Medicine)
- Article from:
- Internal Medicine News
- Article date:
- July 1, 2005
- Author:
CopyrightCOPYRIGHT 2005 International Medical News Group. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
WASHINGTON -- Patients who received bivalirudin as their anticoagulant during percutaneous coronary intervention required fewer transfusions than did those treated with unfractionated heparin, based on a post hoc analysis of data from a study of 6,010 patients.
This effect appeared to protect against mortality during the subsequent year, Steven V. Manoukian, M.D., reported in a poster at a meeting sponsored by the Cardiovascular Research Institute at Washington Hospital Center.
"These are the first data to suggest that a difference in antithrombotic therapy can influence the transfusion rate. It is a way to reduce the risk from blood transfusions," he ...